MENU
Showcases Stock ranks Forex

Ironwood Pharmaceuti (IRWD)
11.7  -0.17 (-1.43%) 08-08 16:00
Open: 11.95 Pre. Close: 11.87
High: 11.965 Low: 11.515
Volume: 2,652,914 Market Cap: 1,800M
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 11.977 - 12.038 12.038 - 12.085
Low: 11.38 - 11.443 11.443 - 11.492
Close: 11.599 - 11.706 11.706 - 11.788
Stock Technical Analysis
Overall:     
Target: Six months: 14.59
One year: 17.04
Support: Support1: 11.43
Support2: 10.78
Resistance: Resistance1: 12.49
Resistance2: 14.59
Pivot: 11.69
Moving Averages: MA(5): 11.41
MA(20): 11.72
MA(100): 11.84
MA(250): 11.96
MACD: MACD(12,26): -0.05
Signal(12,26,9): -0.02
%K %D: %K(14,3): 52.83
%D(3): 39.51
RSI: RSI(14): 50.57
52-Week: High: 14.27
Low: 10.13
Change(%): -12.5
Average Vol(K): 3-Month: 3932
10-Days: 3221
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ IRWD ] has closed below upper band by 49.2%. Bollinger Bands are 51.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
Stock chart
Stock News
Mon, 08 Aug 2022
The 3.7% return this week takes Ironwood Pharmaceuticals' (NASDAQ:IRWD) shareholders three-year gains to 25% - Yahoo Sports

Thu, 04 Aug 2022
Today's Stock Market News & Events: 8/4/2022 - MarketBeat

Thu, 04 Aug 2022
Ironwood Pharma Misses Q2 EPS by 12c; Reiterates Outlook By Investing.com - Investing.com India

Thu, 04 Aug 2022
Ironwood: Q2 Earnings Snapshot - SFGATE

Wed, 03 Aug 2022
Ironwood Pharmaceuticals : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.com

Mon, 01 Aug 2022
Shell Asset Management Co. Sells 9445 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers—Specialty & Generic
Shares Out. (M) 153.84
Shares Float (M) 134.43
% Held by Insiders 1.80
% Held by Institutions 111.75
Shares Short (K) 17510
Shares Short Prior Month (K) 14080
Stock Financials
EPS 3.290
Book Value (p.s.) 3.340
Profit Margin 124.83
Operating Margin 57.91
Return on Assets (ttm) 18.2
Return on Equity (ttm) 167.9
Qtrly Rev. Growth 9.8
Gross Profit (p.s.) 2.232
Sales Per Share 2.746
EBITDA (p.s.) 1.600
Qtrly Earnings Growth -15.10
Operating Cash Flow (M) 252.32
Levered Free Cash Flow (M) 147.22
Stock Valuation
PE Ratio 3.56
PEG Ratio 0.13
Price to Book value 3.50
Price to Sales 4.26
Price to Cash Flow 7.13
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android